Last reviewed · How we verify
intravenous rescue atropine administration
At a glance
| Generic name | intravenous rescue atropine administration |
|---|---|
| Also known as | IRAA |
| Sponsor | Michał Stasiowski |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair (NA)
- Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: